不同路径植入静脉输液港并发症的临床研究
Clinical Application on Complications of Implantable Venous-Access Port through Different Routes
DOI: 10.12677/ACM.2022.121034, PDF,    科研立项经费支持
作者: 李 磊, 邹建军, 谢亚琳, 苏 宁, 苏 珊, 岑文昌：广州市胸科医院肿瘤科，广东 广州；张 晖：广州市胸科医院放射科，广东 广州
关键词: 股静脉；锁骨下静脉；颈内静脉；输液港；并发症；Femoral Vein； Subclavian Vein； Jugular Vein； Implantable Venous Access Port； Complication
摘要: 目的：评价股静脉、锁骨下静脉、颈内静脉全植入术治疗恶性肿瘤的安全性及并发症临床应用。方法：选择2016年9月至2020年12月接受植入式静脉输液港的286例患者开展回顾性分析，全植入式静脉通路端口286个，其中股静脉43个、颈内静脉100个、锁骨下静脉143个，分析患者术后3组不同植入路径发生并发症的影响因素。结果：286例全植入术静脉通道中发生并发症77例(26.9%)，其中导管阻塞16例，血流感染14例，皮肤破裂7例，中央静脉血栓形成6例，导管移位3例，回抽无回血6例。286个完全可植入式静脉通路中未发现年龄、性别、输液港位置、肿瘤类型、导管类型与并发症有相关性(P > 0.05)。股静脉组术后血栓症发生率高于锁骨下静脉和颈内静脉组(P < 0.05)。股静脉回抽无回血发生率高于锁骨下静脉组术后(P < 0.05)。在非计划取港率和其他并发症上差异无统计学意义(P > 0.05)。结论：经股静脉、锁骨下静脉或颈内静脉全植入式静脉通道移植在恶性肿瘤患者中是安全可行的，且通道相关并发症发生率低。
Abstract: Objective: To evaluate the safety and complications of totally implantable venous access port implantation via femoral vein, subclavian vein or internal jugular vein in patients with malignancy. Method: A total of 286 totally implantable venous access ports were placed in 286 patients with malignancy between Sep 2016 and Dec 2020 (43 via femoral vein, 100 via jugular vein and 143 via subclavian vein). The influencing factors of postoperative complications in 3 groups of patients with different implantation paths were analyzed. Result: Among the 286 cases of total implantation, 77 cases (26.9%) had complications, including catheter obstruction in 16 cases, bloodstream infection in 14 cases, skin rupture in 7 cases, central venous thrombosis in 6 cases, catheter displacement in 3 cases, and no blood return in 6 cases. There was no correlation between age, gender, infusion port location, tumor type, catheter type and complications in 286 fully implantable venous pathways (P > 0.05). The incidence of postoperative thrombosis in the femoral vein group was higher than that in the subclavian vein group and the internal jugular vein group (P < 0.05). The incidence of no blood return in the femoral vein was higher than that in the subclavian vein group (P < 0.05). There was no significant difference in unplanned port taking rate and other complications (P > 0.05). Conclusion: These data indicate that totally implantable venous access port implantation via the femoral vein, subclavian vein or internal jugular vein in patients with malignancy is safe and feasible, with a low access-related complication rate.
文章引用：李磊, 张晖, 邹建军, 谢亚琳, 苏宁, 苏珊, 岑文昌. 不同路径植入静脉输液港并发症的临床研究[J]. 临床医学进展, 2022, 12(1): 223-228. https://doi.org/10.12677/ACM.2022.121034

参考文献

[1] Niederhuber, J.E., Ensminger, W., Gyves, J.W., Liepman, M., Doan, K. and Cozzi, E. (1982) Totally Implanted Venous and Arterial Access System to Replace External Catheters in Cancer Treatment. Surgery, 92, 706-712.
[2] 陈学瑜, 李成, 赵广垠, 陈中元, 朱良纲. 两种方式静脉输液港植入手术的临床研究[J]. 医学研究杂志, 2020(9): 155-160.
[3] Ozyuvaci, E. and Kutlu, F. (2006) Totally Implantable Venous Access Devices via Subclavian Vein: A Retrospective Study of 368 Oncology Patients. Advances in Therapy, 23, 574-581. [Google Scholar] [CrossRef] 
[4] Xu, H., Chen, R., Jiang, C., You, S., Zhu, Q., Li, Y., Li, S., Zha, X. and Wang, J. (2020) Implanting Totally Implantable Venous Access Ports in the Upper Arm Is Feasible and Safe for Patients with Early Breast Cancer. The Journal of Vascular Access, 21, 609-614. [Google Scholar] [CrossRef] [PubMed]
[5] Tabatabaie, O., Kasumova, G.G., Eskander, M.F., Critchlow, J.F., Tawa, N.E. and Tseng, J.F. (2017) Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies. American Journal of Clinical Oncology, 40, 94-105. [Google Scholar] [CrossRef] 
[6] 许立超, 李文涛, 陆箴琦. 全程管理是中心静脉通路安全保障[J]. 介入放射学杂志, 2017(8): 673-675.
[7] Plumhans, C., Mahnken, A.H., Ocklenburg, C., Keil, S., Behrendt, F.F., Günther, R.W. and Schoth, F. (2011) Jugular Versus Subclavian Totally Implantable Access Ports: Catheter Position, Complications and Intrainterventional Pain Perception. European Journal of Radiology, 79, 338-342. [Google Scholar] [CrossRef] [PubMed]
[8] 刘霞, 俞娟, 高薇. 经股静脉植入静脉输液港在晚期肿瘤病人中的临床应用[J]. 全科护理, 2016(6): 579-581.
[9] 孙玉巧, 周涛, 李云涛, 王建新, 焦俊琴, 王昊绮, 耿翠芝. 完全植入式静脉输液港的临床应用[J]. 中华外科杂志, 2014, 52(8): 608-611.
[10] Marcy, P.Y., Lacout, A., Figl, A. and Thariat, J. (2011) “Letter to the Editor re: “Outcome Analysis in 3160 Implantations of Radiologically Guided Placements of Totally Implantable Central Venous Port Systems”: Observations about Right Internal Jugular Access. European Radiology, 21, 2166-2167. [Google Scholar] [CrossRef] [PubMed]
[11] Ma, L., Liu, Y., Wang, J., Chang, Y., Yu, L. and Geng, C. (2016) Totally Implantable Venous Access Port Systems and Associated Complications: A Single-Institution Retrospective Analysis of 2,996 Breast Cancer Patients. Molecular and Clinical Oncology, 4, 456-460. [Google Scholar] [CrossRef] [PubMed]
[12] Arveswaran, J., Burke, D. and Bodenham, A. (2007) Cephalic Vein Cut-Down verses Percutaneous Access: A Retrospective Study of Complications of Implantable Venous Access Devices. The American Journal of Surgery, 194, 699. [Google Scholar] [CrossRef] [PubMed]
[13] Lebeaux, D., Larroque, B., Gellen-Dautremer, J., Leflon-Guibout, V., Dreyer, C., Bialek, S., Froissart, A., Hentic, O., Tessier, C., Ruimy, R., Pelletier, A.L., Crestani, B., Fournier, M., Papo, T., Barry, B., Zarrouk, V. and Fantin, B. (2012) Clinical Outcome after a Totally Implantable Venous Access Port-Related Infection in Cancer Patients: A Prospective Study and Review of the Literature. Medicine (Baltimore), 91, 309-318. [Google Scholar] [CrossRef] 
[14] Wu, S., Huang, J., Jiang, Z., Huang, Z., Ouyang, H., Deng, L., Lin, W., Guo, J. and Zeng, W. (2016) Internal Jugular Vein versus Subclavian Vein as the Percutaneous Insertion Site for Totally Implantable Venous Access Devices: A Meta-Analysis of Comparative Studies. BMC Cancer, 16, Article No. 747. [Google Scholar] [CrossRef] [PubMed]
[15] Goltz, J.P., Scholl, A., Ritter, C.O., Wittenberg, G., Hahn, D. and Kickuth, R. (2010) Peripherally Placed Totally Implantable Venous-Access Port Systems of the Forearm: Clinical Experience in 763 Consecutive Patients. CardioVascular and Interventional Radiology, 33, 1159-1167. [Google Scholar] [CrossRef] [PubMed]
[16] Ruesch, S., Walder, B. and Tramèr, M.R. (2002) Complications of Central Venous Catheters: Internal Jugular versus Subclavian Access—A Systematic Review. Critical Care Medicine, 30, 454-460. [Google Scholar] [CrossRef] [PubMed]
[17] Bademler, S., Üçüncü, M., Yıldırım, İ. and Karanlık, H. (2019) Risk Factors for Complications in Cancer Patients with Totally Implantable Access Ports: A Retrospective Study and Review of the Literature. Journal of International Medical Research, 47, 702-709. [Google Scholar] [CrossRef] [PubMed]
[18] Ji, L., Yang, J., Miao, J., Shao, Q., Cao, Y. and Li, H. (2015) Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center. Cell Biochemistry and Biophysics, 72, 235-240. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, T.Y., Lee, K.D., Chen, P.T., Chen, M.C., Chen, Y.Y., Huang, C.E., Kuan, F.C., Chen, C.C. and Lu, C.H. (2015) Incidence and Risk Factors for Central Venous Access Port-Related Infection in Chinese Cancer Patients. Journal of the Formosan Medical Association, 114, 1055-1060. [Google Scholar] [CrossRef] [PubMed]
[20] 余超, 葛坤元, 蒋晓东, 程宝亮, 陈秀峰, 邹晨. 3种不同途径植入静脉输液港的临床应用比较[J]. 复旦学报(医学版), 2021(2): 229-266.

为你推荐